SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs

Purpose: Osteopathy is an emerging complication of acromegaly characterized by increased bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). In somatostatin analog (SSA)- resistant patients (pts), Pegvisomant (PegV) and Pasireotide LAR (Pasi) are used f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiloiro, Sabrina, Giampietro, Antonella, Bianchi, Antonio, Bima, Chiara, Frara, Stefano, Mirra, Federica, Donfrancesco, Federico, Fleseriu, Maria, Pontecorvi, Alfredo, Giustina, Andrea, De Marinis, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553164/
http://dx.doi.org/10.1210/js.2019-SUN-LB075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553164/
http://dx.doi.org/10.1210/js.2019-SUN-LB075

Ejemplares similares